Nova Patents
AT415996T

Partial aortic occlusion devices for cerebral perfusion augmentation

Abstract

This record has no abstract on file.

Term

Term ended

Expired 25 February 2020, 6.6 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

53 members in 7 offices

This recordMember, by publication datePriority claim

Priority claims1

Priority claims
DocumentOfficeKindDate
26037199United States of AmericaA

Members53

Family members, oldest first
DocumentOfficeKind
CA2364014A1CanadaA1
WO0051675A1World Intellectual Property Organization (WIPO)A1
US6231551B1United States of AmericaB1
US2001041860A1United States of AmericaA1
EP1156848A1European Patent Office (EPO)A1
US2002115982A1United States of AmericaA1
CA2444878A1CanadaA1
WO02085443A1World Intellectual Property Organization (WIPO)A1
JP2002537909AJapanA
US2003023200A1United States of AmericaA1
US2003083617A1United States of AmericaA1
US6565552B1United States of AmericaB1
US2003097036A1United States of AmericaA1
US6592557B2United States of AmericaB2
US2003195382A1United States of AmericaA1
US6635046B1United States of AmericaB1
EP1381419A1European Patent Office (EPO)A1
US6712806B2United States of AmericaB2
US6743196B2United States of AmericaB2
US6767345B2United States of AmericaB2
US6796992B2United States of AmericaB2
JP2004533290AJapanA
US2004220521A1United States of AmericaA1
US2005085685A1United States of AmericaA1
US2005124849A1United States of AmericaA1
US2005159640A1United States of AmericaA1
US2006047262A1United States of AmericaA1
US7150736B2United States of AmericaB2
US7166097B2United States of AmericaB2
US2007118095A1United States of AmericaA1
US2007135793A1United States of AmericaA1
EP1156848A4European Patent Office (EPO)A4
US2007239135A9United States of AmericaA9
EP1381419A4European Patent Office (EPO)A4
EP1156848B1European Patent Office (EPO)B1
AT415996TThis recordAustriaT
ATE415996T1AustriaT1
US7468027B2United States of AmericaB2
DE60040969D1GermanyD1
EP2025360A2European Patent Office (EPO)A2
EP2025360A3European Patent Office (EPO)A3
JP4270877B2JapanB2
US2009247884A1United States of AmericaA1
US7867195B2United States of AmericaB2
CA2444878CCanadaC
US2011106132A1United States of AmericaA1
US7993324B2United States of AmericaB2
US2012089167A1United States of AmericaA1
US2013281869A1United States of AmericaA1
US8888740B2United States of AmericaB2
US9566009B2United States of AmericaB2
US2017296196A1United States of AmericaA1
US10335152B2United States of AmericaB2